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Abstract
Background: Here we investigate the effect of millicurrent treatment on human chondrocytes cultivated in a
collagen gel matrix and on human osteochondral explants.
Methods: Human chondrocytes from osteoarthritic knee joints were enzymatically released and transferred into a
collagen type-I gel. Osteochondral explants and cell-seeded gel samples were cultivated in-vitro for three weeks.
Samples of the verum groups were stimulated every two days by millicurrent treatment (3 mA, sinusoidal signal of
312 Hz amplitude modulated by two super-imposed signals of 0.28 Hz), while control samples remained
unaffected. After recovery, collagen type-I, type-II, aggrecan, interleukin-1b, IL-6, TNFa and MMP13 were examined
by immunohistochemistry and by real time PCR.
Results: With regard to the immunostainings 3 D gel samples and osteochondral explants did not show any
differences between treatment and control group. The expression of all investigated genes of the 3 D gel samples
was elevated following millicurrent treatment. While osteochondral explant gene expression of col-I, col-II and Il-1b
was nearly unaffected, aggrecan gene expression was elevated. Following millicurrent treatment, IL-6, TNFa, and
MMP13 gene expression decreased. In general, the standard deviations of the gene expression data were high,
resulting in rarely significant results.
Conclusions: We conclude that millicurrent stimulation of human osteoarthritic chondrocytes cultivated in a 3 D
collagen gel and of osteochondral explants directly influences cell metabolism.
Background
Electrical stimulation for pain relief is a well established
method in physical therapy centres. Mostly, it is com-
bined with other treatments like massage, heat or physi-
cal manipulation. There are many commercial electrical
stimulation devices available, which are commonly
referred as transcutaneous electrical nerve stimulation
units. These devices emit electrical pulses with alternat-
ing positive and negative polarities in the 10-500 kHz
range and currents in the milliampere range. While
units using higher currents are more effective in block-
ing acute pain, pain relief of units which deliver currents
in the microampere range and frequencies from 0.5 to
several hundred Hz can endure for several hours after
end of treatment [1]. Polk et al investigated the benefi-
cial effects of microcurrent treatment on soft tissue [2].
Clinically, diseases of the human locomotive system like
pseudarthrosis have been treated with electromagnetic
techniques since 1975 [3]. While some studies describe
phenomenological effects of microcurrent treatment, the
exact mechanism how microcurrent stimulation might
affect chondrocytes in the hyaline cartilage environment
remains unknown. When pressure is applied on hyaline
cartilage, a change of electrical potentials can be
observed which might induce intracellular changes in
biosynthesis [4-6]. An enhancement of chondrogenic
differentiation and of synthesis of cartilage extracellular
matrix proteins has been described [7,8]. Additionally,
the effect of microcurrent treatment on voltage-sensitive
sodium and calcium ion channels is well documented
[9]. One may speculate that these membrane-bound
integrins may be involved in current signal transduction.
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To our knowledge this is the first study which investi-
gates the effect of millicurrent on human articular chon-
drocytes and on human osteochondral explants on the
biochemical level. Nevertheless, the exact mode of
action has to be elucidated in future studies.
Methods
Preparation of collagen gel seeded with human
chondrocytes
Cartilage samples without any bone remnants were har-
vested from knee joints of 10 patients (2 male, 8 female;
mean age 67.8) undergoing total knee replacement due
to osteoarthritis. Only cartilage from morphologically
unaffected regions from Outerbridge grade 3-4 patients
[10] were included in the study. All patients gave their
written consent prior to operation. The study was
approved by the local ethics committee of the Aachen
University Hospital.
Samples were collected in DMEM medium containing
10% fetal calf serum (FCS), 100 U/ml penicillin, and 100
μg/ml streptomycin. The cartilage was cut into 1-2 mm3
pieces, and digested with 1 mg/ml Liberase 3 (Roche
Diagnostics, Indianapolis, MN, USA) overnight. The
released chondrocytes were washed subsequently for
3 times, and cell number was determined by CASY1 cell
counter (Schärfe System, Reutlingen, Germany).
Rat tail collagen type-I gel was provided by Arthro
Kinetics (Esslingen, Germany). The collagen type-I was
supplied as an aqueous solution of 6 mg/ml in 0.1%
acetic acid. It remained liquid when stored at 4°C and
gelled when transferred to 37°C.
2 × 105 chondrocytes/ml gel were resuspended in
1 vol collagen type-I gel mixed with 1 vol 2× DMEM/
2 M HEPES (0.93:0.07), resulting in a final concentra-
tion of 2 × 105 chondrocytes/ml gel. 1.5 ml cell-seeded
collagen gel was given into each well of a 12-well-plate
and allowed to gel for 30 min. After gelling, samples
were overlaid with DMEM/FCS medium and cultivated
under standardized in-vitro conditions (37°C, 5% CO2,
humidified atmosphere) for up to 3 weeks. Every three
days, samples were fed with fresh medium.
Stimulation of cell-seeded collagen gel samples
Stimulation of collagen gel samples seeded with human
chondrocytes was carried out by the Algonix device
(Medilab, Würzburg, Germany).
Sterile electrodes with a diameter of 3 mm were
inserted at a distance of 3 cm on opposite sites into the
cell-seeded gel samples. With a current of 3 mA stimu-
lation was carried out twice for 30 sec consecutively
with a sinusoidal signal of 312 Hz amplitude. The signal
was modulated by 2 super-imposed signals with 2 differ-
ent frequencies of 0.28 Hz (Fig. 1). By this, a current
density of 10.6 A/cm2 was achieved. Stimulation was
repeated every two days. After up to 3 weeks, samples
were recovered. One part of the specimens was pro-
cessed for histological evaluation, while the remaining
served for determination of gene expression.
The treatment group consisted of 10 independent
samples of 10 patients. Ten samples of the same
patients were left untreated and were cultivated in paral-
lel as a control.
Collection and stimulation of osteochondral explants
Human articular osteochondral samples consisting of
cartilage and the underlying bone were harvested from
knee joints of 10 patients (3 male, 7 female; mean age
67.2 years) undergoing total knee replacement due to
osteoarthritis. Only specimens from morphologically
unaffected regions from Outerbridge grade 3-4 patients
was included in the study. All patients gave their written
consent prior to operation. Samples were collected in
DMEM medium containing 10% fetal calf serum (FCS),
100 U/ml penicillin, and 100 μg/ml streptomycin under
sterile conditions.
Sterile electrodes with a diameter of 3 mm were
pressed on opposite sites on the explants at a distance
of 3 cm, while covered with medium. Every two days,
stimulation was carried out as described and repeated
twice. Osteochondral explants were cultivated under
standard in-vitro conditions (37°C, 5% CO2, humidified
atmosphere) for 3 weeks. As a control group, osteo-
chondral explants from the same patients were left
Figure 1 Diagram of millicurrent stimulation. Diagram of
stimulation applied to cell-seeded collagen type-I gel samples and
osteochondral explants. Electrodes of 3 mm in diameter were
inserted at a distance of 3 cm. A current of 3 mA was applied;
stimulation was carried out for 30 sec with a sinusiodal signal of
312 Hz amplitude modulated by two super-imposed signals of 0.28
Hz. Stimulation was repeated consecutively twice every two days for
up to 3 weeks.
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untreated and cultivated in parallel. After recovery, one
part of the specimens was processed for histological eva-
luation. Cartilage from the remaining was depleted, and
chondrocytes were released by enzymatic digestion as
described. The released chondrocytes were subject to
determination of gene expression.
Histochemical and immunocytochemical analysis
Osteochondral explants were fixed and decalcified for
4 weeks and subsequently embedded in paraffin, while
collagen gel samples were fixed overnight in a phos-
phate-buffered solution of 4% Para formaldehyde and
embedded in paraffin. 5 μm sections were stained with
hematoxylin-eosin and safranin O according to standard
protocols.
For detection of collagen type-II protein, sections were
deparaffinized, blocked and incubated with a polyclonal
antibody to human collagen type-II (Biotrend, Cologne,
Germany) diluted 1:50 overnight. Collagen type-I was
detected by incubation of 1:200 diluted polyclonal anti-
body (Cedarlane, Hornby, Canada) overnight. Il-1b was
visualized using a monoclonal antibody specific to
human IL-1b (HyTest, Turku, Finland), while IL-6 was
detected with a monoclonal antibody by the same man-
ufacturer. TNFa protein was stained overnight with a
polyclonal antibody 1:500 diluted by Abcam, Cambridge,
USA. MMP-13 was detected by incubation with a 1:100
diluted monoclonal antibody (Chemicon, Temecula, CA,
USA) at 4°C overnight.
Proliferating cells were detected by indirect immuno-
histochemistry using the Ki-67 polyclonal antibody
(NeoMarkers, Fremont, CA, USA) staining an antigen
specific for proliferating cells.
Apoptotic cells were detected by TUNEL staining of
fragmented DNA (Dead End Colorimetric Apoptosis
Detection System, Promega, Madison, WI, USA) accord-
ing to the manufacturer’s instruction.
Immunohistological staining was visualized using the
streptavidin/biotin technique (Vectastain ABC Kit,
Vector Laboratories, Burlingame, VT, USA). Diamino-
benzidine (DAB Peroxidase Substrate Kit, Vector
Laboratories, Burlingame, VT, USA) was used as the
developing substrate leading to a brownish color of the
immunopositive cells. The specificity of the staining was
verified by omission of the primary antibody and the
use of matrix samples without enclosed cells, giving the
background staining.
All images were captured by a Leica microscope
(Leica, Wetzlar, Germany) and prepared using the
Discus software by the same manufacturer.
Analysis of mRNA expression
RNA was isolated with the Oligotex Direct mRNA
Kit (Quiagen, Hilden, Germany) according to the
manufacturer’s instruction. Isolated mRNA was used to
create the corresponding cDNA by the SuperScript II
First Strand Synthesis System (Invitrogen, Carlsbad, CA,
USA). Gene expression of collagen type-II, collagen
type-I, aggrecan, MMP-13, IL-6, Il-1b and TNFa was
quantified by real time PCR on a LightCycler (Roche
Diagnostics, Indianapolis, MN, USA). The housekeeping
gene b-actin was used as an internal standard. Because
of the large variability between the patients, data were
presented as relative expression with respect to
untreated control samples of the same patients. Primer
sequences: Col-I (5-prime: GAGGGCCAAGACGAAGA-
CATCC; 3-prime: CACAGAGGGAACCCAGGGAGC),
Col-II (5-prime: CTGGTCCTTCTGGCCCTAGAG;
3-prime: AAAGGCGGACATGTCGATG), Aggrecan (5-
prime: ATGCCCAAGACTACCAGTGG; 3-prime:
TCCTGGAAGCTCTTCTCAGT) Il-1b (5-prime:
TTTCCTGTTGTCTACACCAATGCC; 3-prime:
GGGCTTTAAGTGAGTAGGAGAGG). TNFa and
b-actin primer pairs were purchased from R&D Systems,
Minneapolis, MN, USA. IL-6 and MMP-13 primer pairs
were purchased from Maxim Biotech, San Francisco,
CA, USA.
Statistical analysis
For statistical evaluation the ANOVA test with repeated
measurements was performed. An alpha level of 0.05
was chosen as the desired overall significance level.
Results
Stimulation of articular chondrocytes cultivated in
a 3D matrix
The collagen type-I gel was easily and homogeneously to
mix with the freshly prepared chondrocytes. It could be
poured into samples of different size, was easy to handle
with a forceps and remained stable even when cultivated
for 3 weeks in-vitro. Millicurrent stimulation did not lead
to a remarkable improvement of the mechanical stability.
In all samples cells remained viable, as TUNEL stain-
ing revealed. Regardless of stimulation only few prolifer-
ating cells could be detected (data not shown).
In both control samples and samples stimulated by
millicurrent treatment chondrocyte phenotype was pre-
vailed to a large extent, although some cells showed
signs of a partial morphological dedifferentiation (Fig.
2A). Proteoglycans were produced in both treatment
and control specimens and stored mainly in the
immediate cellular vicinity of the control group, while
some cells of the treatment group started to build a
matrix stretching out in the extracellular space (Fig. 2B).
Collagen type-II protein was produced in both control
samples and millicurrent-treated samples and stored
mainly pericellularly. The building of a territorial matrix
characteristic for hyaline cartilage could not be observed
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under the given in-vitro conditions (Fig. 3). The amount
of collagen type-II protein as detected by semi-quantita-
tive immunohistological staining did not reveal any
obvious differences between control and millicurrent-
treated samples, as did collagen type-I and proteogly-
cans (data not shown).
When looking at the relative col-II gene expression
levels of stimulated samples in relation to control sam-
ples of the same patients, millicurrent stimulation led to
an increase of gene expression (Fig. 4). Even after
3 weeks of in-vitro cultivation, col-II gene expression
was about 1.8-times elevated (p = 0.48 [1 week], p =
0.03 [2 weeks], p = 0.12 [3 weeks]). The increased col-II
gene expression remained on a relatively constant level
throughout the cultivation period. In contrast to col-II,
there was no clear elevation of aggrecan gene expression
detectable. After 3 weeks, aggrecan gene expression
level was elevated to 1.3 (p = 0.45 [1 week], p = 0.35
[2 weeks], p = 0.34 [3 weeks]).
When looking at collagen type-I, gene expression was
strongly elevated during the early cultivation period and
was slowly decreasing while the cultivation proceeded. It
was 4-times elevated after one week of cultivation; after
3 weeks, the elevation of col-I expression had decreased
to 1.5 (p = 0.45 [1 week], p = 0.11 [2 weeks], p = 0.47
[3 weeks]).
Figure 2 H&E and safranin O staining of in-vitro cultivated specimens. Hematoxylin-eosin staining (A) and safranin O staining (B) of
collagen type-I gel seeded with human chondrocytes and cultivated for 1 and 3 weeks in-vitro. Samples were either left untreated (control) or
stimulated by millicurrent treatment. Original magnification ×630.
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Figure 3 Collagen type-II immunostaining of in-vitro cultivated specimens. Immunohistological staining of collagen type-II protein in cell-
seeded collagen gel samples left untreated or stimulated by millicurrent treatment after 1 and 3 weeks of in-vitro cultivation. Collagen type-II
was detected mainly pericellularely. Original magnification ×630.
0
1
2
3
4
1 week 2 weeks 3 weeks
1.22
0.94
1.29
0
1
2
3b
7 7d
a
1 week 2 weeks 3 weeks
1.76
1.72
1.83
*
0
1
2
3
4
5
6
1 week 2 weeks 3 weeks
2.95
2.66
1.54
c
0
1
2
3
4
5
6
1 week 2 weeks 3 weeks
2.96
3.12 2.31
Figure 4 Real-time PCR analysis of matrix-specific genes. Real time PCR analysis of col-II (a), aggrecan (b), col-I (c) and interleukin-1b (d)
gene expression. Data are given as relative gene expression of stimulated samples in relation to gene expression of untreated samples of the
same patients, which were set as 1. B-actin gene expression was included as internal standard. Given are mean +/- SD. N = 10. P = 0.05.
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With respect to the interleukin-1b gene expression, we
found an 3-fold elevation for the treatment group after
one week, which was decreasing to a 2.3-fold elevation
after 3 weeks of cultivation (p = 0.16 [1 week], p = 0.16
[2 weeks], p = 0.38 [3 weeks].
Stimulation of osteochondral explants
After in-vitro cultivation for 3 weeks, millicurrent stimu-
lation did not lead to a macroscopic improvement of
osteochondral explants. HE, safanin O and col-II stain-
ing did not reveal any obvious differences between con-
trol and treatment group, as did staining for IL-1b, IL-6,
TNFa and MMP13 (data not shown). Additionally,
TUNEL staining showed only single apoptotic cells in
both groups (data not shown).
In contrast to semi-quantitative detection of protein
production, determination of gene expression revealed
some differences. The absolute and relative gene expres-
sion data are given in Fig. 5. While gene expression of
collagen type-I and type-II was nearly unaffected, aggre-
can gene expression was elevated by 1.75 fold (p = 0.45)
in treatment samples with respect to control samples of
the same patients. IL1b gene expression showed an
equivalent level in both control and treatment group,
while IL-6 gene expression in the treatment group
decreased to 0.22 (p = 0.16). Treatment group MMP-13
gene expression decreased to 0.55 (p = 0.19), and TNFa
decreased to 0.48 (p = 0.87) relative to control samples
of the same patients.
Discussion
Many efforts have been undertaken to improve matrix-
based tissue engineering of hyaline cartilage, including
manipulation of physical parameters like oxygen supply,
improvements of matrix systems or stimulation with
growth factors. Until now, only few studies have focused
on the effects of stimulating articular chondrocytes with
current treatment. Current stimulation of soft tissue for
pain relief is a well established method since the 1980
[11-14]. Normally, it is combined with conventional
methods like massage, heat or physical manipulation.
While previous studies stimulated with current ranging
from 20 μA to 600 μA [11,15,16], we applied a current
of 3 Milliampere. This corresponds to a protocol which
was successfully applied in pain treatment and post-
operative rehabilitation by the manufacturer of the
Algonix-device. Therefore, this slightly enhanced current
was used in our study. Frank et al artificially damaged
bovine articular cartilage by trypsin digestion and
applied impedance analysis to the treatment site. They
found that tissue impedance directly correlated with the
degree of degradation [17].
To at least partly avoid cellular dedifferentiation, we
chose to carry out the examinations on human
chondrocytes embedded in a collagen type-I gel. Col-
lagen gels are used as a matrix system for the cultivation
of chondrocytes for many years and are of growing
importance for tissue engineering of hyaline cartilage
[18,19]. Additionally, osteochondral explants were sub-
ject for millicurrent stimulation.
Only little is known of the effects of current treatment
of chondrocytes on the biochemical level. We found
that cell metabolism of human chondrocytes is affected
by current treatment in the milliampere range. We
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Figure 5 Real-time PCR analysis of osteochondral explants. (a)
Gene expression of various genes of matrix synthesis, turnover and
inflammation of osteochondral explants left untreated (left column)
or stimulated by millicurrent treatment (right column). Specimens
were cultivated in-vitro for 3 weeks. The housekeeping-gene b-actin
was used as internal standard. P = 0.05. (b) Calculated relative gene
expression of treatment samples in relation to control samples of
the same patients, where gene expression of control samples was
set as 1.
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applied a current density of 10.6 mA/cm2, which should
allow cellular stimulation. Investigating important genes
of cartilage turnover, with respect to chondrocytes culti-
vated in a 3 D matrix in-vitro, we found a more univer-
sal up-regulation rather than a specific one. Aggrecan
and collagen type-II gene expression, which is character-
istic for hyaline cartilage, stayed elevated, while expres-
sion of the collagen type-I gene, indicating
dedifferentiated chondrocytes, was slowly decreasing
during cultivation. Immunohistological examination of
protein production did not show any obvious enhance-
ments with regard to col-II, col-I and proteoglycan pro-
duction. This may be due to the relatively short
cultivation period of 3 weeks. In contrast, when we trea-
ted osteochondral explants, we observed a specific pat-
tern of gene expression, with some genes being
stimulated (col-I, aggrecan), some genes being repressed
(IL-6, MMP-13, TNF-a) and some left unaffected (col-
II, IL-1b). One may speculate that the mechanisms of
signal transduction are different with regard to 3 D gel
culture and osteochondral explant culture, eventually
because of missing ECM components in the collagen
gel. On the other hand, we recently demonstrated a
changed expression profile of a subset of integrins
involved in signal transduction when we investigated
chondrocytes with different states of differentiation [20].
Therefore, a different expression profile of signal-trans-
ducers of chondrocytes cultured in 3 D or explant cul-
ture may be involved.
Todd et al investigated the effects of electrical micro-
currents generated by the ACE Stimulator on human
dermal fibroblasts in-vitro [21]. They found that cell
growth and viability were not influenced. When we
were stimulating human articular chondrocytes with
millicurrent, proliferation and apoptosis were unaffected,
confirming these observations. They also observed an
up-regulation of TGF-b1, which is an important regula-
tor of cell-mediated inflammation and tissue regenera-
tion. TGF-b1 secretion level was increased about
20-30%. We addressed the question of an inflammatory
response to millicurrent therapy by monitoring the gene
expression of Il-1b, IL-6 and TNFa.
Interleukin 1b plays a central role in the pathophysiol-
ogy of cartilage damage and degradation in arthritis. It
promotes the resolution system of cartilage matrix turn-
over through an increase in inflammatory cytokine and
matrix metalloproteinase production by chondrocytes
[22,23]. We found Il-1b gene expression to be elevated
in chondrocytes cultivated in a 3 D matrix, while osteo-
chondral explants did not show any differences.
When investigating Interleukin-6, Todd et al found no
effect of microcurrent stimulation on dermal fibroblasts,
while our results revealed a down-regulation following
millicurrent treatment of osteochondral explants. IL-6 is
not found in normal adult articular chondrocytes. It is
strongly induced by the action of Il-1b [24]. In the pre-
sence of soluble IL-6 receptor, IL-6 has been shown to
activate osteoclasts to induce bone resorption in vitro,
suggesting that IL-6 may be involved in osteoporosis [25].
The proinflammatory cytokine tumor necrosis factor
alpha (TNF-a) is not only critical for host defense
against microbial agents but also plays an important
role in joint inflammation and cartilage destruction in
various forms of arthritis. TNF-a is expressed in the
synovial lining cells and is present in the synovial fluid
from patients with rheumatoid arthritis (RA) or osteoar-
thritis (OA) [26]. TNF-a is capable of activating the
three subgroups of mitogen-activated protein (MAP)
kinases in synovial fibroblasts and chondrocytes i.e.
extracellular signal-regulated kinase (ERK), c-Jun
Nterminal kinase (JNK), and p38 [27,28]. It has been
reported that one or all of these MAP kinases are
involved in regulation of IL-1b and MMP gene expres-
sion [29]. Regarding our results, TNFa gene expression
was down-regulated following millicurrent treatment of
osteochondral explant.
Additionally, we found gene expression of matrix
metalloproteinase 13 (collagenase 3) to be down-regu-
lated in osteochondral explants following millicurrent
treatment. MMP13 levels are increased in cartilage and
synovium of patients with arthritis [30-32]. Forsyth et al
demonstrated that MMP13 expression is increased in
aging human chondrocytes and could contribute to car-
tilage catabolism in osteoarthritis [33].
In summary, important genes of matrix degradation
and inflammation are down-regulated in human osteo-
chondral explants stimulated by millicurrent treatment
in-vitro. Unfortunately, we found a high variation in
gene expression between different donors, resulting in
rarely significant gene expression data. Although we
used cartilage tissue only from those patients with
advanced osteoarthritis and undergoing total knee
arthroplasty and from macroscopically unaffected areas,
there was certainly some variability between the differ-
ent donors. Therefore, strictly speaking, our results have
to be interpreted as a strong indication rather than a
proof. They have to be confirmed by further studies
with a larger patient number.
In general, millicurrent therapy seems not only to sup-
press pain, but to directly influence cell metabolism in a
selective way. This view is supported by our data. As no
specific influence of millicurrent treatment on chondro-
cytes grown in 3 D gel culture could be demonstrated,
the use in cartilage tissue engineering might be limited.
The present work is limited to a phenomenological
description of the millicurrent influence on chondrocyte
metabolism. The underlying mechanisms have to be
elucidated in future studies.
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Conclusion
We demonstrated that millicurrent therapy directly sti-
mulates cell metabolism of human articular chondro-
cytes in human explants in a selective way. Therefore,
millicurrent treatment may support regeneration of
affected cartilage and may be a helpful tool to comple-
ment conventional therapy. Because of the demonstrated
unspecific cellular stimulation with regard to 3 D gel
culture, the benefits in cartilage tissue engineering
might be limited.
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